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Introduction
------------

The role of iNOS in MOF has been controversial, studies having presented contradicting results, however, the use of more specific inhibitors of iNOS may provide benefit.

Aim
---

To examine the effects of iNOS inhibition in our model of TAA induced MOF.

Method
------

MOF was induced by two intraperitoneal (IP) injections of TAA (500 mg/kg) eight hours apart. Three groups were studied, Group 1 receiving TAA only. Group 2 and 3 followed thr protocol for Group 1, however, Group 2 was pre-treated with the NO precursor L-Arginine (300 mg/kg IP) once daily and Group 3 was pre-treated with NO synthase inhibitor aminoguanidine (100 mg/kg SC) for three days.

Results
-------

See Table. n=10 Mean ± SD.

Histology
---------

The histological sections show markedly less organ damage in the aminoguanidine group (Group 3).

Conclusion
----------

Inhibition of iNOS using aminoguanidine significantly improves the incidence of MOF and mortality in the TAA model of MOF.

  Groups        AST (iu/l)   Creatinine (umol/l)   Lactate mmol/l   Survival %                         
  ------------- ------------ --------------------- ---------------- ------------ ---------- ---------- -----
  Control         34± 10       41± 12                43± 13           51± 10     1.5± 0.3   1.4± 0.2   100
  TAA           1653± 164    4045± 247             167± 22          231± 37      3.9± 0.9   6.2± 0.7   25
  TAA + L-ARG   2177± 231    4475± 240             187± 14          271± 27      4.2± 0.5   7.3± 0.7   10
  TAA + AMG     346± 50      1090± 188             87± 21           112± 23      2.1± 0.2   3.4± 0.3   90
